Physician profile
Rachel E Meltzer
NPI 1346779600
$45,092.77
in general payments reported to CMS, 2019-2025
5 companies · $30K in 2025
The $30K reported for 2025 was more than what 95% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.99 · 2022: $888 · 2023: $4,533 · 2024: $9,452 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $32K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,450 · Education: $4,509 · Food and Beverage: $1,246 · Travel and Lodging: $24.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,875.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,450.00 |
| Education | $4,509.26 |
| Food and Beverage | $1,245.86 |
| Travel and Lodging | $24.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $39,308.16 | 2023-2025 | Nemluvio |
| Sun Pharmaceutical Industries INC. | $5,397.47 | 2022-2023 | |
| Janssen Biotech, INC. | $230.22 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $124.99 | 2025 | |
| Abbvie INC. | $31.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Meltzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.